NCT06152796View on ClinicalTrials.gov

Comparision Between Paracetamol and Ibuprofen in Closure of Patent Ductus Arteriosus

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

September 1, 2025

Study Completion Date

January 1, 2026

Conditions

Patent Ductus Arteriosus

Interventions

DRUG

Paracetamol

Anti\_inflammatory drug

DRUG

Ibuprofen

Non steroidal anti\_inflammatory drug

All Listed Sponsors

lead

Assiut University

OTHER